Stephen Berenson

Stephen Berenson (board member) discloses dealings in 2 companies, chiefly Moderna, Inc. and Seres Therapeutics, Inc. The record holds 6 filings, for trades running from 11 December 2018 to 3 May 2024.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.

On 7 May 2024 came the latest disclosure, an option exercise in Moderna, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.